Kingfa Science & Technology Stocks

4263.2Last Updated 08.04.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

₹ 613.43M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
4263.2
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Kingfa Science & Technology (India) Limited manufactures and supplies reinforced polypropylene compounds and fiber reinforced composites in India. It also offers thermoplastic elastomers under the HYPRENE brand name; POM; fiberglass honeycomb composite panels; LFT products; PA6/PA66 products; engineering plastics compounds; and high temperature resistant nylon/LCP. The company supplies its products to automobile, electronic appliances, induproductsstrial equipment, consumer goods, packaging, toys, etc. The company was formerly known as Hydro S&S Industries Limited and changed its name to Kingfa Science & Technology (India) Limited in March 2016. The company was incorporated in 1983 and is based in Chennai, India. Kingfa Science & Technology (India) Limited is a subsidiary of Kingfa Sci. & Tech. Co., Ltd.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks